Cronos Group (CRON) Insider Trading & Ownership → Could this Tiny Biotech End Disease Forever? (From Behind the Markets) (Ad) Free cron Stock Alerts $2.60 -0.04 (-1.52%) (As of 03:33 PM ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Cronos Group (NASDAQ:CRON) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage1.96%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$434,250.00Number OfInsiders Selling(Last 12 Months)0 Get CRON Insider Trade Alerts Want to know when executives and insiders are buying or selling Cronos Group stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CRON Insider Buying and Selling by Quarter Ad Behind the MarketsCould this Tiny Biotech End Disease Forever?Imagine a revolutionary treatment capable of editing out ANY disease. By literally "cutting" the genetic instructions that cause illness, and "pasting" in corrected DNA to restore perfect health.Access my full "Cut & Paste" profit analysis now. Cronos Group Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/30/2023Jason Marc AdlerDirectorBuy37,500$1.74$65,250.00 5/25/2023Jason Marc AdlerDirectorBuy100,000$1.80$180,000.00 5/19/2023Jason Marc AdlerDirectorBuy100,000$1.89$189,000.00 (Data available from 1/1/2013 forward) CRON Insider Trading Activity - Frequently Asked Questions Who is on Cronos Group's Insider Roster? The list of insiders at Cronos Group includes Jason Marc Adler. Learn more on insiders at CRON. What percentage of Cronos Group stock is owned by insiders? 1.96% of Cronos Group stock is owned by insiders. Learn more on CRON's insider holdings. Which Cronos Group insiders have been buying company stock? The following insider purchased CRON shares in the last 24 months: Jason Marc Adler ($1,736,855.00). How much insider buying is happening at Cronos Group? Insiders have purchased a total of 685,000 CRON shares in the last 24 months for a total of $1,736,855.00 bought. More Insider Trading Tools from MarketBeat Related Companies: USANA Health Sciences Insider Transactions Canopy Growth Insider Transactions Mind Medicine (MindMed) Insider Transactions biote Insider Transactions MannKind Insider Transactions Vir Biotechnology Insider Transactions AbCellera Biologics Insider Transactions Scholar Rock Insider Transactions Prothena Insider Transactions Warby Parker Insider Transactions Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 3 Penny Stocks That Insiders Are BuyingThe 3 Hottest Insiders Buys This Month 3 Companies Buying Back Cheap Stock LatelyPagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year This page (NASDAQ:CRON) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersAI “wealth window” is closing June 25thParadigm PressElon Musk Secret Crypto Plot ExposedCrypto 101 MediaThe AI Stock that’s Disrupting Every IndustryStockEarningsShocking: One AI startup's revenue could surge 4,735%Manward PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsCharles Payne Demystifies OptionsUnstoppable ProsperityWatch this FREE trading tutorial while it’s still availableInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cronos Group Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.